Smith Group Asset Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Smith Group Asset Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-6,740	Closed	-$33K	–	481
2016 Q4	$33K	Hold	6,740	–	–	﹤0.01%	353
2016 Q3	$311K	Buy	6,740 +1,810	+37%	+$102K	0.01%	215
2016 Q2	$252K	Sell	4,930 -100	-2%	-$4.97K	0.01%	229
2016 Q1	$213K	Buy	5,030 +4,835	+2,479%	+$246K	0.01%	209
2015 Q4	$15K	Sell	195 -30	-13%	-$1.74K	﹤0.01%	414
2015 Q3	$9K	Sell	225 -30	-12%	-$1.59K	﹤0.01%	354
2015 Q2	$13K	Buy	+255	New	+$12.7K	﹤0.01%	340
2015 Q1	–	Sell	-28,810	Closed	-$1.29M	–	460
2014 Q4	$1.29M	Sell	28,810 -2,700	-9%	-$113K	0.05%	168
2014 Q3	$1.23M	Buy	+31,510	New	+$1.24M	0.05%	169

Other funds holding ISEE

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

BIM

Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Smith Group Asset Management's ISEE Position: Q1 2017 in Review

Smith Group Asset Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q1 2017, closing a stake of 6,740 shares — an estimated $33K sold.

Smith Group Asset Management first reported a position in ISEE in Q3 2014 and held it in 9 quarters. The position peaked at $1.29M in Q4 2014. 100 funds tracked by Wall St. Rank hold ISEE as of Q1 2017.

Smith Group Asset Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
Smith Group Asset Management sold 6,740 IVERIC bio, Inc. Common Stock shares in Q1 2017, an estimated $33K.
Smith Group Asset Management first reported a position in IVERIC bio, Inc. Common Stock in Q3 2014 and held it in 9 quarters.
Smith Group Asset Management's IVERIC bio, Inc. Common Stock position peaked at $1.29M in Q4 2014.
100 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2017.

Based on Smith Group Asset Management's 13F filing for Q1 2017, filed 4 May 2017.